Page last updated: 2024-11-05

triazolam and Aura

triazolam has been researched along with Aura in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gandolfo, G1
Scherschlicht, R1
Gottesmann, C1

Other Studies

1 other study available for triazolam and Aura

ArticleYear
Benzodiazepines promote the intermediate stage at the expense of paradoxical sleep in the rat.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 49, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Diazepam; Electroencephalography; Epilepsy; Eye Movements; Heart Rate;

1994